302 related articles for article (PubMed ID: 26671825)
21. Role of Uric Acid Metabolism-Related Inflammation in the Pathogenesis of Metabolic Syndrome Components Such as Atherosclerosis and Nonalcoholic Steatohepatitis.
Kushiyama A; Nakatsu Y; Matsunaga Y; Yamamotoya T; Mori K; Ueda K; Inoue Y; Sakoda H; Fujishiro M; Ono H; Asano T
Mediators Inflamm; 2016; 2016():8603164. PubMed ID: 28070145
[TBL] [Abstract][Full Text] [Related]
22. Serum uric acid levels and non-alcoholic fatty liver disease in Uyghur and Han ethnic groups in northwestern China.
Cai W; Wu X; Zhang B; Miao L; Sun YP; Zou Y; Yao H
Arq Bras Endocrinol Metabol; 2013 Nov; 57(8):617-22. PubMed ID: 24343630
[TBL] [Abstract][Full Text] [Related]
23. Hyperuricemia precedes non-alcoholic fatty liver disease with abdominal obesity moderating this unidirectional relationship: Three longitudinal analyses.
Ma Z; Zhang J; Kang X; Xu C; Sun C; Tao L; Zheng D; Han Y; Li Q; Guo X; Yang X
Atherosclerosis; 2020 Oct; 311():44-51. PubMed ID: 32937242
[TBL] [Abstract][Full Text] [Related]
24. [Idiopathic hyperuricemia with overproduction of uric acid].
Mizuta E; Igawa O; Hisatome I
Nihon Rinsho; 2008 Apr; 66(4):675-8. PubMed ID: 18409513
[TBL] [Abstract][Full Text] [Related]
25. Dose-response Relationship of Serum Uric Acid with Metabolic Syndrome and Non-alcoholic Fatty Liver Disease Incidence: A Meta-analysis of Prospective Studies.
Liu Z; Que S; Zhou L; Zheng S
Sci Rep; 2015 Sep; 5():14325. PubMed ID: 26395162
[TBL] [Abstract][Full Text] [Related]
26. [HYPERURICEMIA AND POTENTIAL RISK OF CARDIOVASCULAR AND RENAL DISEASES].
Schils R; Krzesinski JM
Rev Med Liege; 2016 May; 71(5):262-8. PubMed ID: 27337847
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of and risk factors for non-alcoholic fatty liver disease in a Chinese population: An 8-year follow-up study.
Lu ZY; Shao Z; Li YL; Wulasihan M; Chen XH
World J Gastroenterol; 2016 Apr; 22(13):3663-9. PubMed ID: 27053858
[TBL] [Abstract][Full Text] [Related]
28. [Physiology and dynamics of uric acid in hyperuricemia].
Takagi K; Nakamura T; Ueda T
Nihon Rinsho; 2008 Apr; 66(4):669-74. PubMed ID: 18409512
[TBL] [Abstract][Full Text] [Related]
29. Hyperuricemia and risk of nonalcoholic fatty liver disease: a systematic review and meta-analysis.
Gong S; Song J; Wang L; Zhang S; Wang Y
Eur J Gastroenterol Hepatol; 2016 Feb; 28(2):132-8. PubMed ID: 26545082
[TBL] [Abstract][Full Text] [Related]
30. Insulin-like growth factor 1 and metabolic parameters are associated with nonalcoholic fatty liver disease in obese children and adolescents.
Liang S; Cheng X; Hu Y; Song R; Li G
Acta Paediatr; 2017 Feb; 106(2):298-303. PubMed ID: 27889912
[TBL] [Abstract][Full Text] [Related]
31. Associations of hyperuricemia and obesity with remission of nonalcoholic fatty liver disease among Chinese men: A retrospective cohort study.
Yang C; Yang S; Feng C; Zhang C; Xu W; Zhang L; Yan Y; Deng J; Ohore OE; Li J
PLoS One; 2018; 13(2):e0192396. PubMed ID: 29415050
[TBL] [Abstract][Full Text] [Related]
32. Hyperuricaemia and non-alcoholic fatty liver disease (NAFLD): a relationship with implications for vascular risk?
Katsiki N; Athyros VG; Karagiannis A; Mikhailidis DP
Curr Vasc Pharmacol; 2011 Nov; 9(6):698-705. PubMed ID: 21388346
[TBL] [Abstract][Full Text] [Related]
33. Prevalence and Risk Factors of Hyperuricemia in Patients with Chronic Kidney Disease and Non-Alcoholic Fatty Liver.
Golmohammadi S; Tavasoli M; Asadi N
Clin Exp Gastroenterol; 2020; 13():299-304. PubMed ID: 32903892
[TBL] [Abstract][Full Text] [Related]
34. Uric acid: role in cardiovascular disease and effects of losartan.
Alderman M; Aiyer KJ
Curr Med Res Opin; 2004 Mar; 20(3):369-79. PubMed ID: 15025846
[TBL] [Abstract][Full Text] [Related]
35. Hyperuricaemia and risk of nonalcoholic fatty liver disease: A meta-analysis.
Wijarnpreecha K; Panjawatanan P; Lekuthai N; Thongprayoon C; Cheungpasitporn W; Ungprasert P
Liver Int; 2017 Jun; 37(6):906-918. PubMed ID: 27891768
[TBL] [Abstract][Full Text] [Related]
36. The significance of serum xanthine oxidoreductase in patients with nonalcoholic fatty liver disease.
Zhang J; Xu C; Zhao Y; Chen Y
Clin Lab; 2014; 60(8):1301-7. PubMed ID: 25185415
[TBL] [Abstract][Full Text] [Related]
37. Relationship between serum uric acid levels and hepatic steatosis in non-obese postmenopausal women.
Liu PJ; Ma F; Lou HP; Zhu YN; Chen Y
Climacteric; 2014 Dec; 17(6):692-9. PubMed ID: 24884478
[TBL] [Abstract][Full Text] [Related]
38. The role of xanthine oxidoreductase and uric acid in metabolic syndrome.
Battelli MG; Bortolotti M; Polito L; Bolognesi A
Biochim Biophys Acta Mol Basis Dis; 2018 Aug; 1864(8):2557-2565. PubMed ID: 29733945
[TBL] [Abstract][Full Text] [Related]
39. Value and Progress of Ultrasound in Diagnosis and Treatment of Hyperuricemia.
Gao Z; Lü K
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Apr; 39(2):280-284. PubMed ID: 28483030
[TBL] [Abstract][Full Text] [Related]
40. Hyperuricemia-induced NLRP3 activation of macrophages contributes to the progression of diabetic nephropathy.
Kim SM; Lee SH; Kim YG; Kim SY; Seo JW; Choi YW; Kim DJ; Jeong KH; Lee TW; Ihm CG; Won KY; Moon JY
Am J Physiol Renal Physiol; 2015 May; 308(9):F993-F1003. PubMed ID: 25651569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
